ArticleViruses2022

Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus.

Rebecca Shipley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.